Rivaroxaban to prevent clots in cancer patients with new catheters
Treatments studied
Part of Cancer, Heart & circulation clinical trials.
This Phase 3 study tests whether the medicine rivaroxaban can prevent dangerous blood clots in people with cancer who have a central venous catheter placed recently. It may help reduce clot risk while your catheter is in place, but you must meet safety and bleeding-risk criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older and have a new or existing cancer diagnosis
- You had a central venous catheter (CVC) placed within the last 72 hours
- Your CVC has not already been in place for more than 72 hours
- You are not already required to take blood thinners (anticoagulation) for another reason
- You have not had major bleeding in the last 4 weeks, and you do not have very high bleeding risk conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether rivaroxaban, a blood thinner pill, can help prevent dangerous blood clots in people with certain genitourinary cancers who are starting cancer treatment. It may lower clot risk, but it also has bleeding-risk tradeoffs that the study will monitor closely.
This study tests whether the blood thinner edoxaban can safely prevent blood clots caused by a central venous catheter in cancer patients. It may be an option if you have a catheter and are not already on blood thinners.
This study tests whether a lower dose of the blood thinner apixaban (Eliquis) can safely prevent another blood clot in people with cancer who have a catheter-related clot in their upper arm or neck. It aims to find a balance between preventing clots and reducing bleeding risk.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
This study tests a simple plan for stopping and restarting your blood thinner (DOAC) before and after getting a port or tunneled catheter. It aims to make the procedure safer for people with cancer who need blood thinners.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.